Kidney function and blood biomarkers of Alzheimer’s disease and neurodegeneration: a systematic review and meta-analysis
Background: Blood biomarkers of neurodegeneration and Alzheimer’s disease (AD) are increasingly used for early detection and risk stratification; however, systemic conditions such as reduced kidney function may influence their circulating concentrations and complicate their interpretation. Objective: To evaluate the as...